Open Access
Med Sci (Paris)
Volume 34, Number 11, Novembre 2018
Page(s) 925 - 927
Section Le Magazine
Published online 10 December 2018
  1. Alsafadi S, Mobuchon L, Rodrigues M, Stern M-H. Le mélanome uvéal- Une maladie modèle des anomalies de l’épissage et de l’oncogenèse. Med Sci (Paris) 2018 ; 34 : 155–160. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  2. Rodrigues M, Mobuchon L, Houy A, et al. Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors. Nat Commun 2018 ; 9 : 1866. [CrossRef] [PubMed] [Google Scholar]
  3. Algazi AP, Tsai KK, Shoushtari AN, et al. Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies. Cancer 2016 ; 122 : 3344–3353. [CrossRef] [PubMed] [Google Scholar]
  4. Alexandrov LB, Jones PH, Wedge DC, et al. Clock-like mutational processes in human somatic cells. Nat Genet 2015 ; 47 : 1402–1407. [Google Scholar]
  5. Sjolund AB, Senejani AG, Sweasy JB. MBD4 and TDG: multifaceted DNA glycosylases with ever expanding biological roles. Mutat Res 2013 ; 743–744 : 12–25. [PubMed] [Google Scholar]
  6. Bellacosa A, Cicchillitti L, Schepis F, et al. MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1. Proc Natl Acad Sci U S A 1999 ; 96 : 3969–3974. [CrossRef] [PubMed] [Google Scholar]
  7. Hendrich B, Hardeland U, Ng HH, et al. The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites. Nature 1999 ; 401 : 301–304. [CrossRef] [PubMed] [Google Scholar]
  8. Millar CB, Guy J, Sansom OJ, et al. Enhanced CpG mutability and tumorigenesis in MBD4-deficient mice. Science 2002 ; 297 : 403–405. [Google Scholar]
  9. Wong E, Yang K, Kuraguchi M, et al. Mbd4 inactivation increases Cright-arrowT transition mutations and promotes gastrointestinal tumor formation. Proc Natl Acad Sci U S A 2002 ; 99 : 14937–14942. [CrossRef] [PubMed] [Google Scholar]
  10. Tricarico R, Cortellino S, Riccio A, et al. Involvement of MBD4 inactivation in mismatch repair-deficient tumorigenesis. Oncotarget 2015 ; 6 : 42892–42904. [CrossRef] [PubMed] [Google Scholar]
  11. Sanders MA, Chew E, Flensburg C et al. MBD4 guards against methylation damage and germline deficiency predisposes to clonal hematopoiesis and early-onset AML. Blood 2018; pii: blood-2018-05-852566. doi: 10.1182/blood-2018-05-852566. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.